AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

NEXT STORY
atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression
PREV STORY
Oncternal Therapeutics to Participate in September Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results

RADNOR, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or ...

author_avatar
NASDAQ Market News

BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region

CAMBRIDGE, Mass. and BEIJING, China and SAN DIEGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

American Health Council Names Sarah Forsythe, MS, RN, BSN to Nursing Board

NEW YORK, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Sarah Forsythe, Clinical Quality Specialist at ...

author_avatar
NASDAQ Market News